BIOMAT Database Logo BIOMAT Database Logo

Ganciclovir pre-emptive therapy for cytomegalovirus antigenemia in a pemphigus vulgaris patient. 2019

Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Department of Dermatology, Gifu Prefectural Tajimi Hospital, Gifu, Japan.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008297 Male Males
D010392 Pemphigus Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS. Pemphigus Vulgaris,Pemphigus Foliaceus,Foliaceus, Pemphigus
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience.
November 1998, Bone marrow transplantation,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial.
September 2000, Transplantation,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Cytomegalovirus colitis in a patient with pemphigus vulgaris.
April 2016, European journal of dermatology : EJD,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
November 2001, Herpes : the journal of the IHMF,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
December 2005, Transplant international : official journal of the European Society for Organ Transplantation,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
October 2003, Bone marrow transplantation,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Effective pre-emptive therapy with Ganciclovir and specific immunoglobulins for CMV infection in a bone marrow transplanted patient.
January 1992, Haematologica,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients.
October 2010, Transplant international : official journal of the European Society for Organ Transplantation,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.
April 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Akitaka Shibata, and Takenori Yoshikawa, and Sumiko Makita, and Norito Takami, and Takuro Matsuzaki, and Yutaka Sugiyama, and Masashi Akiyama
Efficacy of a strategy for discontinuing pre-emptive ganciclovir therapy after a negative cytomegalovirus antigenaemia test result in seropositive kidney transplant recipients.
May 2013, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!